Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 21.48
(-2.27%)
CNY 21.48
(-2.27%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 601.65 Million CNY | 5.49% |
| 2022 | 570.36 Million CNY | -0.73% |
| 2021 | 574.56 Million CNY | 8854.4% |
| 2020 | 6.41 Million CNY | -80.96% |
| 2019 | 33.7 Million CNY | 3270.0% |
| 2018 | 1 Million CNY | 0.0% |
| 2017 | 1 Million CNY | 0.0% |
| 2016 | 1 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 527.02 Million CNY | -19.75% |
| 2024 Q1 | 609.14 Million CNY | 1.24% |
| 2024 Q2 | 656.74 Million CNY | 7.81% |
| 2023 Q1 | 579.01 Million CNY | 1.52% |
| 2023 FY | 601.65 Million CNY | 5.49% |
| 2023 Q4 | 601.65 Million CNY | 0.79% |
| 2023 Q3 | 596.91 Million CNY | 1.55% |
| 2023 Q2 | 587.82 Million CNY | 1.52% |
| 2022 Q4 | 570.36 Million CNY | 1.05% |
| 2022 Q3 | 564.44 Million CNY | 1.55% |
| 2022 Q2 | 555.85 Million CNY | 1.53% |
| 2022 Q1 | 547.5 Million CNY | -4.71% |
| 2022 FY | 570.36 Million CNY | -0.73% |
| 2021 Q2 | 1.95 Million CNY | -51.04% |
| 2021 Q1 | 3.99 Million CNY | -37.8% |
| 2021 Q3 | 28.8 Million CNY | 1374.26% |
| 2021 Q4 | 574.56 Million CNY | 1894.4% |
| 2021 FY | 574.56 Million CNY | 8854.4% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 6.41 Million CNY | -80.96% |
| 2020 Q4 | 6.41 Million CNY | -89.23% |
| 2020 Q3 | 59.6 Million CNY | 36.7% |
| 2020 Q2 | 43.6 Million CNY | 0.0% |
| 2019 Q2 | 29.8 Million CNY | 0.0% |
| 2019 Q4 | 33.7 Million CNY | 0.0% |
| 2019 FY | 33.7 Million CNY | 3270.0% |
| 2018 FY | 1 Million CNY | 0.0% |
| 2017 FY | 1 Million CNY | 0.0% |
| 2016 FY | 1 Million CNY | 0.0% |